+ All Categories
Home > Documents > ATI Cleveland Clinic Poster

ATI Cleveland Clinic Poster

Date post: 13-Feb-2017
Category:
Upload: bruce-fraser
View: 316 times
Download: 2 times
Share this document with a friend
1
The Theraworx Silver First Protocol: Impact on CatheterAssociated Urinary Tract Infec?ons REFERENCES RESULTS INTRODUCTION Study Design and Popula2on This was a quality improvement project undertaken from June through August 2014 at Euclid Hospital, a Cleveland Clinic Hospital. Ten units parEcipated in the study. The Theraworx Silver First protocol was used for urinary catheter inserEon and maintenance (Figure 1). Study Defini2ons A CAUTI was defined according to current Centers for Disease Control and PrevenEon NaEonal Healthcare Safety Network definiEons. Sta2s2cal Analysis To evaluate the impact of Theraworx on CAUTI prevenEon, a staEsEcal process control uchart (rates over Eme from a Poisson distribuEon) was used. Montgomery rules were used to determine specialcause variaEon on the charts (4). June 2014 was considered a washout period in which training was being conducted and therefore those data were not included in the analysis. Figure 1: Theraworx Silver First Protocol CONCLUSIONS Although no special cause variaEon was idenEfied on the staEsEcal process control chart, we were able to reach and maintain zero CAUTI aUer implementaEon of the Theraworx Silver First Protocol. Theraworx provides many benefits over many other anEsepEcs including a broad spectrum of acEvity, pH maintenance, and it is safe to use in the perirectal area/mucus membranes. The Theraworx Silver First Protocol may be an effecEve CAUTI prevenEon intervenEon. 1. Klevens RM, Edwards JR, Richards CL, Horan TC, Gaynes RP, Pollock DA, et al. EsEmaEng health careassociated infecEons and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2): 1606. 2. Tambyah PA, Knasinski V, Maki DG. The direct costs of nosocomial catheterassociated urinary tract infecEon in the era of managed care. Infect Control Hosp Epidemiol. 2002;23(1):2731. 3. Gould CV, Umscheid CA, Agarwal RK, et al. Guideline for Preven.on of CatheterAssociated Urinary Tract Infec.ons 2009. Healthcare InfecEon Control PracEces Advisory Commibee (HICPAC), 2009. hbp://www.cdc.gov/hicpac/pdf/CAUTI/CAUTIguideline2009final.pdf. Accessed July 28, 2014. 4. Montgomery DC. IntroducEon to staEsEcal quality control. 6th ed. Hoboken, N.J.: Wiley; 2009. xiv, 734 Poster fully funded by “Eblen Chari?es” Catheterassociated urinary tract infecEons (CAUTI) are very common healthcareassociated infecEons in the United States (1). This burden results in hundreds of millions of dollars of excess healthcare costs, with significant associated morbidity and mortality (2). The majority of CAUTIs are preventable through infecEon prevenEon intervenEons (3). NaEonal guidelines recommend cleaning the periurethral area with anEsepEc soluEons but do not recommend rouEne use of anEsepEcs for catheter maintenance (3). However, the lack of recommendaEon for anEsepEc use for catheter maintenance is due to the lack of available evidence to make an evidencebased decision and is not a contraindicaEon. The objecEve of this quality improvement project was to evaluate the impact of Theraworx, a novel skin anEsepEc, for urinary catheter inserEon and maintenance for the prevenEon of CAUTI in hospitalized paEents. METHODS Figure 2: Catheterassociated Urinary Tract InfecEon (CAUTI) Rate January 2013 – August 2014 ChrisEne M. Tusoch 1 RN, BSN, CIC; Kimberly A. Kovacic 1 RN; Timothy L. Wiemken 2 PhD, MPH, CIC; 1. Euclid Hospital, Cleveland OH; 2. University of Louisville, Louisville, KY Study Period
Transcript

The  Theraworx  Silver  First  Protocol:    Impact  on  Catheter-­‐Associated  Urinary  Tract  Infec?ons      

REFERENCES

RESULTS INTRODUCTION

Study  Design  and  Popula2on  This   was   a   quality   improvement   project   undertaken   from   June  through  August  2014  at  Euclid  Hospital,  a  Cleveland  Clinic  Hospital.  Ten   units   parEcipated   in   the   study.     The   Theraworx   Silver   First  protocol  was  used  for  urinary  catheter  inserEon  and  maintenance  (Figure  1).    Study  Defini2ons  A   CAUTI   was   defined   according   to   current   Centers   for   Disease  Control   and   PrevenEon   NaEonal   Healthcare   Safety   Network  definiEons.  Sta2s2cal  Analysis  To   evaluate   the   impact   of   Theraworx   on   CAUTI   prevenEon,   a  staEsEcal  process  control  u-­‐chart   (rates  over  Eme  from  a  Poisson  distribuEon)  was  used.  Montgomery  rules  were  used  to  determine  special-­‐cause  variaEon  on  the  charts  (4).  June  2014  was  considered  a   washout   period   in   which   training   was   being   conducted   and  therefore  those  data  were  not  included  in  the  analysis.  

Figure  1:    Theraworx  Silver  First  Protocol  

CONCLUSIONS q Although  no  special  cause  variaEon  was  idenEfied  on  the  staEsEcal  process  control  chart,  we  were  able  to  reach  and  maintain  zero  CAUTI  aUer  implementaEon  of  the  Theraworx  Silver  First  Protocol.      

q Theraworx   provides   many   benefits   over   many   other   anEsepEcs   including   a   broad   spectrum   of   acEvity,   pH  maintenance,  and  it  is  safe  to  use  in  the  peri-­‐rectal  area/mucus  membranes.  

q The  Theraworx  Silver  First  Protocol  may  be  an  effecEve  CAUTI  prevenEon  intervenEon.      

1.  Klevens  RM,  Edwards  JR,  Richards  CL,  Horan  TC,  Gaynes  RP,  Pollock  DA,  et  al.  EsEmaEng  health  care-­‐associated  infecEons  and  deaths  in  U.S.  hospitals,  2002.  Public  Health  Rep.  2007;122(2):160-­‐6.  

2.  Tambyah  PA,  Knasinski  V,  Maki  DG.  The  direct  costs  of  nosocomial  catheter-­‐associated  urinary  tract  infecEon  in  the  era  of  managed  care.  Infect  Control  Hosp  Epidemiol.  2002;23(1):27-­‐31.  

3.  Gould  CV,  Umscheid  CA,  Agarwal  RK,  et  al.  Guideline  for  Preven.on  of  Catheter-­‐Associated  Urinary  Tract  Infec.ons  2009.  Healthcare  InfecEon  Control  PracEces  Advisory  Commibee  (HICPAC),  2009.  hbp://www.cdc.gov/hicpac/pdf/CAUTI/CAUTIguideline2009final.pdf.    Accessed  July  28,  2014.  

4.  Montgomery  DC.  IntroducEon  to  staEsEcal  quality  control.  6th  ed.  Hoboken,  N.J.:  Wiley;  2009.  xiv,  734  

Poster  fully  funded  by  “Eblen  Chari?es”  

Catheter-­‐associated   urinary   tract   infecEons   (CAUTI)   are   very  common  healthcare-­‐associated   infecEons   in  the  United  States  (1).    This   burden   results   in   hundreds   of   millions   of   dollars   of   excess  healthcare   costs,   with   significant   associated   morbidity   and  mortality  (2).        The   majority   of   CAUTIs   are   preventable   through   infecEon  prevenEon   intervenEons   (3).       NaEonal   guidelines   recommend  cleaning  the  periurethral  area  with  anEsepEc  soluEons  but  do  not  recommend   rouEne   use   of   anEsepEcs   for   catheter   maintenance  (3).    However,   the   lack  of   recommendaEon   for   anEsepEc  use   for  catheter  maintenance   is   due   to   the   lack   of   available   evidence   to  make  an  evidence-­‐based  decision  and  is  not  a  contraindicaEon.    The  objecEve  of  this  quality  improvement  project  was  to  evaluate  the   impact   of   Theraworx,   a   novel   skin   anEsepEc,   for   urinary  catheter  inserEon  and  maintenance  for  the  prevenEon  of  CAUTI  in  hospitalized  paEents.  

METHODS Figure  2:    Catheter-­‐associated  Urinary  Tract  InfecEon  (CAUTI)  Rate  January  2013  –  August  2014    

ChrisEne  M.  Tusoch1  RN,  BSN,  CIC;  Kimberly  A.  Kovacic1  RN;  Timothy  L.  Wiemken2  PhD,  MPH,  CIC;          1.    Euclid  Hospital,  Cleveland  OH;  2.  University  of  Louisville,  Louisville,  KY  

Study  Period  

Recommended